These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20491609)

  • 21. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study.
    Kunugi H; Iijima Y; Tatsumi M; Yoshida M; Hashimoto R; Kato T; Sakamoto K; Fukunaga T; Inada T; Suzuki T; Iwata N; Ozaki N; Yamada K; Yoshikawa T
    Biol Psychiatry; 2004 Sep; 56(5):376-8. PubMed ID: 15336520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.
    Grünblatt E; Zehetmayer S; Bartl J; Löffler C; Wichart I; Rainer MK; Jungwirth S; Bauer P; Danielczyk W; Tragl KH; Riederer P; Fischer P
    J Psychiatr Res; 2009 Jan; 43(3):298-308. PubMed ID: 18603262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
    Hwang JP; Tsai SJ; Hong CJ; Yang CH; Lirng JF; Yang YM
    Neurobiol Aging; 2006 Dec; 27(12):1834-7. PubMed ID: 16343697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data.
    Trajkovska V; Marcussen AB; Vinberg M; Hartvig P; Aznar S; Knudsen GM
    Brain Res Bull; 2007 Jun; 73(1-3):143-9. PubMed ID: 17499648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
    Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
    Grassi-Oliveira R; Stein LM; Lopes RP; Teixeira AL; Bauer ME
    Biol Psychiatry; 2008 Aug; 64(4):281-5. PubMed ID: 18406398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants.
    Savitz J; van der Merwe L; Stein DJ; Solms M; Ramesar R
    Biol Psychiatry; 2007 Sep; 62(5):391-9. PubMed ID: 17210134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
    Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
    Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population.
    He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
    Neuropsychobiology; 2007; 55(3-4):151-5. PubMed ID: 17657167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
    Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum brain-derived neurotrophic factor in patients with trauma psychopathology.
    Hauck S; Kapczinski F; Roesler R; de Moura Silveira E; Magalhães PV; Kruel LR; Schestatsky SS; Ceitlin LH
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):459-62. PubMed ID: 20097247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine A2A receptor expression in peripheral blood mononuclear cells of patients with mild cognitive impairment.
    Arosio B; Viazzoli C; Mastronardi L; Bilotta C; Vergani C; Bergamaschini L
    J Alzheimers Dis; 2010; 20(4):991-6. PubMed ID: 20413899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.
    Cunha AB; Frey BN; Andreazza AC; Goi JD; Rosa AR; Gonçalves CA; Santin A; Kapczinski F
    Neurosci Lett; 2006 May; 398(3):215-9. PubMed ID: 16480819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia.
    Tsai SJ; Gau YT; Liu ME; Hsieh CH; Liou YJ; Hong CJ
    Neurosci Lett; 2008 Mar; 433(2):158-62. PubMed ID: 18242855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
    Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
    Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis.
    Blanco Y; Gómez-Choco M; Arostegui JL; Casanova B; Martínez-Rodríguez JE; Boscá I; Munteis E; Yagüe J; Graus F; Saiz A
    Neurosci Lett; 2006 Apr; 396(3):217-9. PubMed ID: 16356643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.